Pharmaceutical Performance Prediction

Path BioAnalytics Inc., ("PBA") is a computational biomedical company building cloud-based, software-enabled drug development tools to enhance the R&D and clinical trial process. Our assays incorporate recent breakthroughs in the fields of statistics, mathematics and machine learning to deliver superior accuracy and maximal biological relevance. Our areas of focus include high-throughput organoid-based assays for CFTR and ENaC modulators, sputum and bronchial alveolar lavage analysis, and mucolytic assays.